老年女性对年龄歧视的实践经验:乳腺癌查超出了目标年龄范围
Joanne Adams1, Virginia Dickson-Swift1, Irene Blackberry2,3
1Violet Vines Marshman Centre for Rural Health Research, La Trobe Rural Health School, La Trobe University, Bendigo, VIC, Australia.
Women's health (London, England)
|December 24, 2025
概括
老年妇女在医疗保健中经历了年龄歧视,影响了她们获得乳腺癌查的机会. 了解这些感知是改善沟通和照顾这一人口群体的关键.
科学领域:
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
- 社会学 社会学 社会学
背景情况:
- 年龄歧视,定义为年龄组之间的偏见,显著影响老年妇女的健康和福祉.
- 医疗互动对老年人来说变得更加具有挑战性,因为伴随疾病的增加和身体知觉的变化.
研究的目的:
- 通过检查老年妇女在接受乳腺癌查时的看法和经历来探索年龄歧视.
- 调查75岁及以上妇女的医疗保健背景下,年龄歧视的多方面的性质.
主要方法:
- 来自60名75岁以上妇女的初级数据的二次定性分析,澳大利亚范围 (2022年).
- 使用NVivo软件进行了深入的个人访谈,并进行了主题分析,结合了老龄化的理论视角和研究人员对社会年龄歧视的反思.
主要成果:
- 妇女报告了基于年龄的医疗保健互动和感知的变化.
- 年龄歧视经历被分为微观,中观和宏观层次,主题包括自主权,不断变化的健康需求和"无形世代".
- 年龄歧视影响健康和福祉,受到同龄人群,代际差异,卫生系统经验,社会因素和技术使用的影响.
结论:
- 识别年龄歧视的层次使医疗保健提供者能够改善老年妇女的沟通和护理.
- 健康信息必须解决隐含和明确的年龄歧视,优先考虑信任,避免过度依赖在线平台.
- 基于年龄的健康促进可能无意中强化了年龄歧视;这些倡议需要仔细考虑.
相关概念视频
01:28Menopause
3.5K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
01:15Drug Dosing: Geriatric Patients
206
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
206
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
174
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
174
02:20Longitudinal Research
13.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
209
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
209
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
205
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
205